Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edith A. Perez, MD
Mayo Clinic
Study Chair - Kathy S. Albain, MD
Loyola University
Study Chair - Margot Burnell
Atlantic Health Sciences Corporation, Saint John NB
Study Chair - Mark N. Levine, MD
Margaret and Charles Juravinski Cancer Centre
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
78 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Bcca - Cancer Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Bcca - Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
- Bcca - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- the Moncton Hospital
Moncton, New Brunswick, Canada
- Atlantic Health Sciences Corporation
Saint John, New Brunswick, Canada
- Dr. H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
- Qeii Health Sciences Center
Halifax, Nova Scotia, Canada
- the Royal Victoria Hospital
Barrie, Ontario, Canada
- Northeast Cancer Center Health Sciences
Greater Sudbury, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston
Kingston, Ontario, Canada
- Grand River Regional Cancer Centre
Kitchener, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Lakeridge Health Oshawa
Oshawa, Ontario, Canada
- Ottawa Health Research Institute - General Division
Ottawa, Ontario, Canada
- Algoma District Cancer Program
Sault Ste. Marie, Ontario, Canada
- the Scarborough Hospital
Scarborough Village, Ontario, Canada
- Niagara Health System
St. Catharines, Ontario, Canada
- Thunder Bay Regional Health Science Centre
Thunder Bay, Ontario, Canada
- Mount Sinai Hospital
Toronto, Ontario, Canada
- Odette Cancer Centre
Toronto, Ontario, Canada
- St. Michael'S Hospital
Toronto, Ontario, Canada
- Trillium Health Centre - West Toronto
Toronto, Ontario, Canada
- Univ. Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Windsor Regional Cancer Centre
Windsor, Ontario, Canada
- Pei Cancer Treatment Centre,queen Elizabeth Hospital
Charlottetown, Prince Edward Island, Canada
- Hopital Charles Lemoyne
Greenfield Park, Quebec, Canada
- Chum - Hopital Notre-Dame
Montreal, Quebec, Canada
- Chum - Hotel Dieu Du Montreal
Montreal, Quebec, Canada
- Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- Sparks-Arkansas Oklahoma Cancer Treatment Centre
Fort Smith, Arkansas, United States
- Hematology Oncology Services of Arkansas
Little Rock, Arkansas, United States
- Scripps Cancer Center
La Jolla, California, United States
- University of Colorado Cancer Centre
Aurora, Colorado, United States
- Greenwich Hospital - Bendheim Cancer Center
Greenwich, Connecticut, United States
- Sibley Memorial Hospital, Oncology Research
Washington D.C., District of Columbia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Dec 2000
- Primary completion
- 10 Feb 2014
- Completion
- 17 Mar 2014
- Last update posted
- 5 Oct 2020
- Registered enrollment
- 2,104
- Registry id
- NCT00014222
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.